Simplex Trading
ODT

Simplex Trading’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Simplex Trading’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,100
Closed -$5K – 11747
2022
Q1 		$5K Sell
4,100
-9,200
-69% -$11.5K ﹤0.01% 9502
2021
Q4 		$1K Sell
13,300
-5,200
-28% -$12.3K ﹤0.01% 10335
2021
Q3 		$62K Hold
18,500
– – ﹤0.01% 7274
2021
Q2 		$64K Buy
18,500
+18,083
+4,336% +$62.1K ﹤0.01% 7355
2021
Q1 		$142K Buy
417
+320
+330% +$6.05K ﹤0.01% 5258
2020
Q4 		$186K Buy
97
+20
+26% +$309 ﹤0.01% 4716
2020
Q3 		$103K Buy
77
+76
+7,600% +$2.15K ﹤0.01% 4880
2020
Q2 		$4K Buy
+1
New +$32 ﹤0.01% 7102

Simplex Trading's ODT Position: Q2 2022 in Review

Simplex Trading sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2022, closing a stake of 2,000 shares — an estimated $2K sold.

Simplex Trading first reported a position in ODT in Q2 2020 and held it in 7 quarters. The position peaked at $202K in Q1 2021. 0 funds tracked by Wall St. Rank hold ODT as of Q2 2022.

  • Simplex Trading reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Simplex Trading sold 2,000 Odonate Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $2K.
  • Simplex Trading first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
  • Simplex Trading's Odonate Therapeutics, Inc. Common Stock position peaked at $202K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.